CARLY BECKNER: Open Payments
NPI 1194028894 · BOWLING GREEN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,433 in 63 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $395 · 2025 $1,433
Food & beverage: $1,255Education: $178
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 6 | $262 |
| UCB, Inc. | 13 | $238 |
| ABBVIE INC. | 16 | $198 |
| Janssen Biotech, Inc. | 3 | $197 |
| Galderma Laboratories, L.P. | 4 | $170 |
| Amgen Inc. | 7 | $109 |
| LEO Pharma Inc. | 4 | $67 |
| Novartis Pharmaceuticals Corporation | 3 | $59 |
| Mallinckrodt Hospital Products Inc. | 1 | $40 |
| Lilly USA, LLC | 2 | $28 |
Products named: DUPIXENT, Bimzelx, TREMFYA, NEMLUVIO, RINVOQ, OTEZLA, ADBRY, SKYRIZI.
Industry payments across KY — which companies pay providers there.
